2 results
Approved WMOPending
To assess the effectivity and safety of 1.0 molar gadobutrol (Gadovist®) for breast MRI
Approved WMOPending
To prospectively assess the potential effect of repeated exposure to either a linear or amacrocyclic gadolinium-based contrast agent (GBCA) on change from baseline to Year 5 inmotor and cognitive function among neurologically normal adults in…